Hepatitis C Antibodies among Blood Donors, Senegal, 2001
2003

Hepatitis C Antibodies among Blood Donors in Senegal

Sample size: 1081 publication 10 minutes Evidence: moderate

Author Information

Author(s): Etard Jean-François, Colbachini Pierre, Dromigny Jacques-Albert, Perrier-Gros-Claude Jean-David

Primary Institution: Institut de Recherche pour le Développement

Hypothesis

What is the prevalence of hepatitis C antibodies among blood donors in Senegal in 2001?

Conclusion

The prevalence of hepatitis C antibodies among blood donors in Dakar in 2001 was found to be 0.8%, one of the lowest in West Africa.

Supporting Evidence

  • The study found that 1.6% of donors had HCV antibodies.
  • First-time donors had a lower prevalence of HCV antibodies compared to repeat donors.
  • HCV infection was more common in older donors.
  • 13% of new donors tested positive for hepatitis B surface antigen.

Takeaway

In 2001, only a small number of blood donors in Dakar had hepatitis C antibodies, which means not many people were infected.

Methodology

Blood donors were screened for HCV antibodies using enzyme immunoassay and confirmed with immunoblot assay.

Potential Biases

Potential bias due to self-selection of volunteer donors and exclusion of individuals with a history of jaundice or risk behaviors.

Limitations

The study did not include systematic screening prior to 2001 and may not represent the entire population of blood donors.

Participant Demographics

The age of donors ranged from 18 to 61 years, with a mean age of 35.6 years, and 81% were men.

Statistical Information

P-Value

p<10–4

Confidence Interval

0.4% to 1.5%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3201/eid0911.030191

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication